摘要:
目的:分析注射用头孢哌酮钠舒巴坦钠在急性尿路感染治疗中的效果与安全性.方法:以我院2016年1月至2016年12月期间收治的80例急性尿路感染患者作为观察样本,采用平行随机抽样法将其分为对照组与观察组各40例,对照组采用甲磺酸左氧氟沙星静脉注射治疗,观察组采用头孢哌酮钠舒巴坦钠静脉注射治疗,观察期14 d,对比两组的临床疗效与不良反应发生情况.结果:(1)治疗后,观察组中显效21例,有效17例,无效2例,总有效率为95%;对照组中显效13例,有效18例,无效9例,总有效率为77.5%,观察组明显高于对照组,具有统计学意义,P0.05.结论:注射用头孢哌酮钠舒巴坦钠在急性尿路感染治疗中的效果确切,而且不良反应少,值得在临床中推广应用.%Objective: to analyze the Cefoperazone Sodium and Sulbactam Sodium for Injection in acute urinary tract infection effect and safety of treatment.Methods: 80 cases of acute urinary tract infection patients as the observation samples in my hospital from January 2016 to December 2016, using parallel randomly divided into control group and observation group with 40 cases in each group, the control group using a sulfonic acid levofloxacin injection treatment, observation group were treated with cefoperazone sodium and sulbactam sodium intravenous injection treatment, the observation period of 14 d, the incidence of adverse reactions were compared with the clinical efficacy of the two groups.Results: (1) after treatment, the observation group of 21 cases were markedly effective, 17 cases effective, 2 cases ineffective, the total efficiency of 95%;control in the group of 13 cases were markedly effective, 18 cases effective, 9 cases ineffective, the total effective rate was 77.5%, the observation group was significantly higher than the control group, with statistical significance, P0.05.Conclusion: the analysis of Cefoperazone Sodium and Sulbactam Sodium for Injection in the treatment of acute urinary tract infection and adverse effect.The reaction is less, it is worth in clinical application.